Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
Abstract Pancreatic cancer is one of the most challenging cancers due to its high mortality rates. Considering the late diagnosis and the limited survival benefit with current treatment options, it becomes imperative to optimize early detection, prognosis and prediction of treatment response. To add...
Main Authors: | María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, Enrique Aranda, Antonio Rodríguez-Ariza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-023-00528-y |
Similar Items
-
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
by: María Victoria García-Ortiz, et al.
Published: (2023-07-01) -
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
by: Marta Toledano-Fonseca, et al.
Published: (2020-07-01) -
Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time?
by: Ankur Sheel, et al.
Published: (2022-07-01) -
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology
by: Francesca Galardi, et al.
Published: (2020-12-01) -
Genetic Analyses of Cell-Free DNA in Pancreatic Juice or Bile for Diagnosing Pancreatic Duct and Biliary Tract Strictures
by: Kosuke Nagai, et al.
Published: (2022-11-01)